香港微科生物技術有限公司榮獲Hong Kong Economic Times (HKCT) 頒發「年度最傑出生物技術產品」獎項,香港微科行政總裁James Chan 應邀出席領獎禮並上台接受獎項。
過去一年,香港微科團隊一直透過專業知識,為客戶提供全面的顧客服務及最先進的生物技術產品。能夠獲得外界嘉許和認可,會成為我們新一年繼續努力的原動力。
香港微科生物技術有限公司榮獲Hong Kong Economic Times (HKCT) 頒發「年度最傑出生物技術產品」獎項,香港微科行政總裁James Chan 應邀出席領獎禮並上台接受獎項。
過去一年,香港微科團隊一直透過專業知識,為客戶提供全面的顧客服務及最先進的生物技術產品。能夠獲得外界嘉許和認可,會成為我們新一年繼續努力的原動力。
Other news
同根同夢 · 2025 全球華人春節聯歡晚會暨楷模人物年度盛典
In view of extraordinary influence in the biotechnological industry, our CEO, James Chan was sincerely
1 月
亞洲最有價值品牌大獎2024
Hong Kong Weike Biotechnology Company Limited was awarded “Most Trusted Biotechnology Solutions Of The Year” of Asia’s
9 月
Scientific Annual Report of CELLBANKERs (2023)
・ The number of citations in 2023 was 266 and reached record high. ・The number of
5 月
2023年度最傑出生物技術產品
Hong Kong Weike Biotechnology Company Limited was awarded「年度最傑出生物技術產品」of the HKCT Business Awards 2023 held by
9 月
Global Cell Freezing Media for Cell Therapy Professional Survey Report
A report titled, “Global Cell Freezing Media for Cell Therapy Professional Survey Report 2022, Forecast
4 月
CELLBANKER’s Scientific Annual Report (2021)
ZENOAQ has issued publications on research of cell cryopreserved regularly. Here is the summary for
2 月